Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy to every patient with cancer.The company's next-generation cell and gene therapies with pharmacologic operating systems provide exquisite control of protein activity in cells and create adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs, enabling patients to improve on the current generation of cell therapies.
Domain
obsidiantx.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$160.5M
Founded
2014
Tech Stack (21 technologies)
Frequently Asked Questions
What technologies does Obsidian Therapeutics use?+
Obsidian Therapeutics uses 21 technologies including AOS, Google Analytics, Google Tag Manager.
What industry is Obsidian Therapeutics in?+
Obsidian Therapeutics operates in the Biotechnology industry.
Where is Obsidian Therapeutics based?+
Obsidian Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026